Natera, Inc. (45E)
XETR
359.50
+7.10 (+2.01%)
Closed
Oct 23, 2026
Day's Range
355.60363.50
52 wk Range
185.45383.30
Overview - 45E - Natera, Inc.
Key Statistics
Trading
Volume
40
Average Volume
30
Peers - 45E - Natera, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XETR.
- 45EXETRNatera, Inc.+46.83%52-week change—P/E (Trailing)—Profit Margin
- TN8XETRThermo Fisher Scientific Inc.+23.57%52-week change37.54P/E (Trailing)15.03%Profit Margin
- QTSXETRIQVIA Holdings Inc.+24.72%52-week change33.78P/E (Trailing)8.09%Profit Margin
- ILUXETRIllumina Inc.+65.94%52-week change52.18P/E (Trailing)18.33%Profit Margin
- BNRXETRBrenntag SE+23.51%52-week change24.46P/E (Trailing)2.40%Profit Margin
- 0MEXETRTwist Bioscience Corporation+64.17%52-week change-64.57P/E (Trailing)-19.84%Profit Margin
- 01PXETRMedpace Holdings, Inc.+29.72%52-week change35.97P/E (Trailing)30.06%Profit Margin
Profile Summary - 45E - Natera, Inc.
About
Natera, Inc. is a molecular diagnostics company that develops and commercializes cell-free DNA and genetic testing services for clinical use. The company focuses on oncology, women’s health, and organ health, using proprietary molecular assays and bioinformatics to help detect and monitor genetic conditions and…
SectorHealthcare
IndustryDiagnostics & Research
Employees4.42K
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
